Nectar Lifescience Ltd share price logo

Nectar Lifescience Ltd

NSE: NECLIFE

BSE: 532649

Small Cap

Pharma Sector

₹11.34

+0.54

(+5.00%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Nectar Lifescience Stock Performance

as on August 13, 2026 at 9:31 pm IST

  • Day's Low

    ₹10.90
    ₹11.34
    downward going graph

    3.88%

    Downside

  • 52 Week's Low

    52 Week's High

    ₹9.30
    ₹22.40
    downward going graph

    17.99%

    Downside

    97.53%

    Upside

    downward going graph

Nectar Lifescience share price movements today

Previous Close
₹10.80
Open
₹10.99
Volume
2.96L
Upper Circuit
₹11.34
Lower Circuit
₹10.26
Day's Low - High
₹10.90 - ₹11.34
52 Week Low - High
₹9.30 - ₹22.40

Nectar Lifescience Historical Returns

1 Month Return
+ 1.34 %
3 Month Return
-11.06 %
1 Year Return
-21.9 %
3 Year Return
-54.09 %
5 Year Return
-62.2 %

Nectar Lifescience Fundamentals

as on August 13, 2026 at 4:01 pm IST

Market Cap

₹220.29 Cr

Return on Equity (ROE)

-11.23

PE Ratio (TTM)

0

Return on capital employed (ROCE)

-5.33

Industry PE ratio

-

Beta (LTM)

1.08

P/B Ratio

0.54

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-47.79

EPS (TTM)

-5.07

Book Value

42.63

Nectar Lifescience Technical Analysis

Track how Nectar Lifescience technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Neutral

Oscillators

Bearish

Neutral

Bullish

Bearish

Overall

Bearish3
Bullish2
Neutral10

Oscillators

Name

Value

Action

MACD level (12,26)
0
Bearish
CCI (20)
35.09
Neutral
RSI (14)
83.2
Bearish
Momentum (10)
0
Neutral
ADI (14)
78.94
Neutral
Ultimate Oscillator (7,14,28)
100
Bullish

Moving Averages

Name

Value

Action

SMA (20)
11.34
Neutral
EMA (20)
11.34
Neutral
VWMA (20)
11.34
Neutral
SMA (50)
11.34
Neutral
EMA (50)
11.34
Neutral
SMA (200)
11.34
Neutral
EMA (200)
11.32
Bullish
KAMA (200)
11.34
Neutral
DEMA (200)
11.39
Bearish

Nectar Lifescience Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nectar Lifescience with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Nectar Lifescience Ltd image
Nectar Lifescience Ltd
NA220.29-12.44%0.69-1141,669
Unjha Formulations Ltd image
Unjha Formulations Ltd
NA12.1034.38%0.00NA15
Krebs Biochemicals & Industries Ltd image
Krebs Biochemicals & Industries Ltd
NA120.59-12.98%0.00-2743
Vineet Laboratories Ltd image
Vineet Laboratories Ltd
NA73.83-11.34%0.00-2175
Aarey Drugs & Pharmaceuticals Ltd image
Aarey Drugs & Pharmaceuticals Ltd
NA260.8622.46%0.004473
See all

Nectar Lifescience Stock’s Investor Sentiment and Interest

Search interest for Nectar Lifescience Ltd Stock has decreased by -4% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-4% versus previous 30 day period

Nectar Lifescience Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
397.96
452.16
439.85
358.85
5.73
-
-
5.23
-
-
-
Other Income
10.61
0.48
1.47
0.55
6.52
8.08
0.18
0.32
0.03
35.46
6.29
Total Income
408.57
452.65
442.84
359.85
12.25
8.08
0.18
5.56
0.74
35.46
7.58
Expenses
371.1
409.98
392.87
319.5
6.32
0.05
130.03
68.63
176.47
1.92
89.24
Operating Profit
26.86
42.18
46.98
39.35
-0.59
-0.05
-130.03
-63.4
-176.47
-1.92
-89.24
Operating Profit Margin %
6.75%
9.33%
10.68%
10.97%
-10.3%
0%
0%
-1212.24%
0%
0%
0%
Profit Before Interest, Tax and Depreciation
37.47
42.67
49.97
40.35
5.93
8.03
-129.85
-63.07
-175.73
33.53
-81.66
Interest
20.52
24.84
24.16
19.98
-
-
-
-
-
30.22
5.9
Depreciation
15.31
15.37
14.7
15.46
0.45
0.07
0.3
0.53
0.11
0.06
0.08
Profit Before Tax
1.64
2.46
11.11
4.91
5.48
7.96
-130.15
-63.6
-175.84
3.25
-87.64
Tax Paid
0.63
0.89
10.52
1.95
-0.12
0.12
-0.06
-0.37
0.16
-11.02
-19.72
Profit After Tax
1.02
1.57
0.59
2.97
5.6
7.84
-130.09
-63.23
-176.01
14.27
-67.92
Total Net profit including share of profit / Loss from associate company
1.02
1.57
0.59
2.97
5.6
7.84
-130.09
-63.23
-176.01
14.27
-67.92
EPS
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
-3.38
Actual EPS
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
-3.38
Adjusted EPS
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
-3.38
Diluted EPS
0.05
0.07
0.03
0.13
0.25
0.35
-5.8
-2.82
-7.85
0.64
-3.38

Nectar Lifescience Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
1,876.26
2,782.86
2,366.38
1,543.3
1,668.83
1,523.67
1,684.09
21.32
-
Other Income
5.58
5.96
4.01
2.72
11.29
42.24
13.03
1.62
7.28
Total Income
1,882.3
2,788.9
2,370.74
1,547.09
1,680.15
1,566.85
1,698.66
22.96
9.29
Expenses
1,640.1
2,518.69
2,146.68
1,459.57
1,510.29
1,470.66
1,532.53
135.59
296.25
Operating Profit
236.16
264.17
219.7
83.73
158.54
53.01
151.56
-114.27
-296.25
Operating Profit Margin %
12.59%
9.49%
9.28%
5.43%
9.5%
3.48%
9%
-535.98%
0%
Profit Before Interest, Tax and Depreciation
242.19
270.21
224.06
87.52
169.86
96.19
166.13
-112.63
-286.95
Interest
115.2
148.14
125.83
112.03
78.81
79.49
87.14
0.01
36.13
Depreciation
64.31
63.26
60.77
60.25
56.97
59.12
60.72
2.08
0.34
Profit Before Tax
62.68
58.81
37.46
-84.76
34.08
-42.42
18.27
-114.72
-323.42
Tax Paid
10.41
11.22
5.68
-11.5
9.03
-18.24
13.27
-1.03
-30.53
Profit After Tax
52.27
47.6
31.79
-73.26
25.05
-24.18
4.99
-113.68
-292.89
Total Net profit including share of profit / Loss from associate company
52.27
47.6
31.79
-73.26
25.05
-24.18
4.99
-113.68
-292.89
EPS
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
-13.4
Actual EPS
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
-13.4
Adjusted EPS
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
-13.4
Diluted EPS
2.33
2.12
1.42
-3.27
1.15
-1.08
0.22
-5.02
-13.4

Nectar Lifescience Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
168.82
198.75
65.17
239.24
284.96
21.38
95.01
133.65
224.69
169.44
Cash Flow from Investing Activities
-76.88
-18.11
-29.43
-26.13
-33.13
-28.62
16.64
51.71
-17.03
-41.93
Cash Flow from Financing Activities
-88.68
-204.12
-39.6
-201.09
-251.87
11.48
-119.38
-185.59
-205.44
-128.09
Net Cash Flow
3.26
-23.47
-3.87
12.02
-0.03
4.25
-7.73
-0.23
2.23
-0.58

Nectar Lifescience Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Jan 2026
Mar 2026
Jun 2026
Promoters
55.8%
55.8%
55.8%
55.8%
55.8%
44.53%
44.53%
44.53%
44.91%
44.91%
51.84%
51.84%
51.84%
DII
0%
0%
0%
0%
0%
0%
0.16%
0.19%
0.09%
5.82%
3.54%
4.01%
3.74%
FII
14.59%
14.59%
16.97%
16.61%
3.24%
0.73%
1.65%
0.81%
0.62%
0.52%
0.58%
0.6%
0.5%
Government
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
Public
28.16%
28.06%
27.21%
27.57%
40.94%
54.72%
53.65%
54.44%
54.37%
48.73%
44.01%
43.52%
43.89%
Total Outstanding Shares
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
22,42,60,970
19,42,60,970
19,42,60,970
19,42,60,970
Total Shareholders
60,283
60,761
59,946
58,230
66,741
69,482
69,241
71,977
76,470
78,124
76,648
74,834
73,834

Mutual Funds that own Nectar Lifescience Stock

Check out the Mutual Funds with significant holdings in Nectar Lifescience.

Funds
Holdings
Shares Held
Bandhan BSE Healthcare Index Fund Direct Growth
Bandhan BSE Healthcare Index Fund Direct Growth
0.01%
1280

Nectar Lifescience Corporate Actions

View detailed summary of the earnings and dividend history of Nectar Lifescience.

  • Nectar Lifescience Ltd Earnings Results

    Nectar Lifescience Ltd’s net profit jumped 47.79% since last year same period to ₹-67.92Cr in the Q4 2025-2026. On a quarterly growth basis, Nectar Lifescience Ltd has generated -575.96% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Nectar Lifescience Ltd Dividends July,2020

    In the quarter ending June 2020, Nectar Lifescience Ltd has declared dividend of ₹0.05 per share on 29 Jul 2020 - translating a dividend yield of 0.46%.

    Read More about Dividends

Indices Featuring Nectar Lifescience Stock

Check stock indices that include Nectar Lifescience.

BSE Healthcare

₹51,034.20

71.23 (▲0.14%)

Insights on Nectar Lifescience Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 43.52% to 43.89% in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 148.1% return, outperforming this stock by 204.4%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.84% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 41.0% return, outperforming this stock by 70.1%

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 0.60% to 0.50% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, NECLIFE stock has moved down by -56.3%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 14.27 Cr → -67.92 Cr (in ₹), with an average decrease of 576.0% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 35.46 Cr → 7.58 Cr (in ₹), with an average decrease of 78.6% per quarter

About Nectar Lifescience Ltd

Nectar Lifesciences Ltd (NLL or NECLIFE) is a globally acclaimed integrated pharmaceutical organization engaged in the manufacture and supply of high quality pharmaceutical products. With a vast network of production sites spread across three Indian states of Punjab, Himachal Pradesh, and Jammu, the organization provides top-notch active pharmaceutical ingredients (API), finished dosage forms, phytochemicals, and hard gelatin capsules to customers in over 90 countries across the world. In addition to manufacturing and marketing cephalosporins and phytochemicals, NECLIFE is also into contract manufacturing of APIs. Established in 1995, the organization has seen a number of expansions, the most recent being in 2019 when they established a unit in Portugal to take over marketing activities from the UK-based wing. They have also launched two new innovative products in the form of menthol capsules and pearl capsules. Focussing on providing quality products, NECLIFE has obtained approval from the Japanese MOH and is well-poised to continue its phenomenal rise in the global pharmaceuticals market.

Revenue: ₹0.00Cr as on March 2026 (Q4 FY26)
Net Profit: ₹-67.92Cr as on March 2026 (Q4 FY26)
Listing date: 18 Jul, 2005
Chairperson Name: Sanjiv Goyal
OrganisationNectar Lifescience Ltd
HeadquartersChandigarh
IndustryPharmaceuticals
CEOSanjiv Goyal
E-voting on sharesClick here to vote

FAQs

What is Nectar Lifescience share price today?

Nectar Lifescience share price today stands at ₹11.34 as on at the close of the market. Nectar Lifescience share today touched a day high of ₹11.34 and a low of ₹10.9.

What is the 52 week high and 52 week low range for Nectar Lifescience share?

Nectar Lifescience touched a 52 week high of ₹22.4 and a 52 week low of ₹9.3. Nectar Lifescience share price today i.e. is closed at ₹11.34, which is -49.38% down from its 52 week high and 21.94% up from its 52 week low.

What is Nectar Lifescience's market capitalisation today?

Nectar Lifescience market capitalisation is ₹220.29 Cr as on .

How to buy Nectar Lifescience shares?

To buy Nectar Lifescience shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for NECLIFE or Nectar Lifescience Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Nectar Lifescience shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Nectar Lifescience trading volume today?

Nectar Lifescience trading volume is 2.96L as on . This means that 2.96L shares of Nectar Lifescience were bought and sold on the stock market during today's trading session.